Auna Corp (AUNA): Forward Price-to-Revenue Multiple
How can drug costs be optimized in Latin America? Centralized procurement at Auna SA (AUNA) solves this problem, and the projected market cap-to-revenue ratio reflects market expectations, with the latest mark standing at 0.00. Growth is driven by mergers with private hospitals and alliances with insurers, while the region's deficit of quality infrastructure protects the dominance of the oncology center network.
Metric breakdowns and analytics for Auna (AUNA)
- current price and projected stock value:
- stock exchange capitalization data:
- business book valuation details:
- debt and solvency information:
Total Debt to Capital Auna SA|AUNA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio aunainvestors.com|AUNA - Company Aggregate Debts|Debt to Book Capitalization Ratio Auna Health|AUNA - Company Long-Term Indebtedness|Company Short-Term Debts Auna|Quick Liquidity Indicator aunainvestors.com
- business earnings and investment ratios data:
AUNA - Profit After Payment of Taxes|Expected Profit Auna SA|AUNA - Company Value to Net Income|Forward P/E Multiple Auna S.A.|AUNA - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Auna|AUNA - Operating profit EBITDA|Net earnings per share for the last 12 months Auna|AUNA - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months aunainvestors.com|AUNA - Net earnings per share growth this year|Earnings growth forecast for next year Auna SA
- sales volume and revenue indicators:
Fundamental company analysis:AUNA (Auna SA)
Forward P/S measures the ratio of current market capitalization to expected revenue, determining the degree of optimism regarding business growth rates already priced in. By analyzing the historical forward P/S, an investor can observe the valuation's sensitivity to earnings reports, which is critical for Auna SA (AUNA) due to the balance between its pricing power in Latin American healthcare and the population's limited solvent demand.
Competitor analysis for Auna SA
Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Forward P/S Multiple PNTG|Market Cap to Expected Sales Ratio Organogenesis Holdings|Forward P/S Multiple NUTX (nutexhealth.com)|SBC Medical Group Holdings Inc (SBC) - Market Cap to Future Revenue Ratio|EOLS - Price-to-Projected Revenue Ratio|Forward Price to Sales CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue MDWD|Price-to-Projected Revenue Ratio biote Corp.|Market Cap to Future Revenue Ratio thejoint.com JYNT|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple P3 Health PIII|Forward P/S Multiple GANX (Gain Therapeutics Inc.)|Forward P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)
